Director, Corporate National Accounts

DescriptionThe Director, Corporate National Accounts (CNA) will serve as the primary relationship owner and strategic lead for a portfolio of national commercial payers, PBMs, and critical downstream accounts. This individual will be responsible for developing and executing payer account strategies that support favorable formulary positioning, reimbursement, and coverage policy for Viaskin® Peanut. The CNA will work cross-functionally with HEOR, medical affairs, contracting, and patient access teams to deliver a compelling value story to payer decision-makers.This role requires a seasoned market access professional who is comfortable navigating complex clinical and policy conversations, building executive-level payer relationships, and operating in a fast-moving, pre-commercial environment.Location: RemoteSalary Range: 240-270kKey ResponsibilitiesAccount Strategy & ExecutionServe as lead for DBV relationship and B2B engagement with assigned accountsIdentify competitive threats and develop response strategies to ensure optimal access for productsDevelop and own account-level plans for assigned national or regional payers, inclusive of formulary strategy, coverage policy objectives, and contracting prioritiesEstablish and maintain executive-level relationships with medical directors, pharmacy directors, and formulary committee decision-makersLead payer negotiations and contracting discussions in partnership with the Market Access contracting team, ensuring alignment with overall pricing strategyValue CommunicationCommunicate the clinical, economic, and humanistic value of Viaskin® Peanut to payer audiences, translating HEOR data and real-world evidence into decision-relevant insightsEffectively articulate the differentiated profile of EPIT as a novel, non-invasive immunotherapy in a competitive and evolving food allergy treatment landscapeDevelop and deliver tailored account-specific value dossiers and budget impact models in collaboration with HEOR and medical affairsPre-Launch & Launch ReadinessAnticipate and proactively address payer policy questions and potential coverage barriers prior to launchPartner with patient services and hub operations to ensure reimbursement pathways are operationally aligned with payer coverage decisionsContribute to the development of payer-facing materials and market access tools in partnership with marketing and regulatoryEstablish KPIs to monitor progress and area of opportunityCross-Functional CollaborationWorks closely with Regional Account Manager(s) and sales leadership to drive field force communications on relevant reimbursement issues and pull through maximizationServe as the voice of the payer internally, providing competitive intelligence, formulary landscape updates, and account-specific feedback to inform brand strategyPartner closely with field outcomes teams to ensure coordinated account engagementRepresent market access in account-level business reviews and brand team planning cyclesQualificationsEducationBachelor’s Degree required; Advanced Degree preferredExperienceA minimum of 10+ years of biotech/pharma of Market Access experience with prior leadership roles in account management and/or sales managementMust complete all required safety and certification training and must maintain an acceptable driving record regarding accidents and incidentsRequires greater than 50% travelExperience integrating Health Economics and Medical Affairs resources into access planningDemonstrated ability to collaborate with a diverse matrix of internal stakeholders (e.g., Market Access Account team, field sales, brand marketing, Medical, legal, compliance, Trade, Patient Services, Data & Analytics) to achieve access goalsAbility to identify future policies, practices and trends that will affect payer management and access decision making in the marketplaceExperience leading pull through efforts with sales leadership and field sales teamsKnowledgeStrong Market Access Payer and PBM (Commercial, and Managed Medicaid) understandingWell-developed negotiation skillsA high level of awareness and understanding of the implications and opportunities of contract strategyExperience identifying trends and insights and assimilating to development of a broader strategyMaintain accurate account profiles and customer interactions via CRM.Technical SkillsAn in-depth knowledge of key account selling for targeted channels/segments.Previous experience in both specialty outpatient at the national account levelExperience in contract development and negotiation with exceptional consultative and networking capabilitiesExperienced in customer negotiation, financial analysis, legal influences, and execution/ implementation of contracting activitiesLeadership & Behavioral SkillsDemonstrated ability to influence the broader organization; motivates others with a positive attitude, leading through adversity and changeThe ability to influence key decision makers in targeted account segmentsStrong executive presence, communication and presentation skills with proven ability to operate and influence cross-functionally and with senior managementStrong financial acumen, analytical skills, and critical thinking abilityProven ability to simultaneously manage numerous priorities, products, projects, etcDemonstrates excellent organization and time management skillsComfort operating in an ambiguous, fast paced, pre-commercial environmentCuriosity – demonstrated desire to learn, explore, and understand new things.Courage – ability to confront fear, uncertainty, and challenges with confidence and resolve.Collaboration -working with others to achieve a common goal.Credibility – builds trust, is reliable, acts with ethics and integrity.DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively.We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin™, to develop treatment options for immunologic diseases with significant unmet medical need.This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the immune system of patients through the skin.Today, we are focused on exploring the use of Viaskin to address food allergies, a devastating condition that afflicts millions of patients. As an important milestone in our journey, we hope to offer the first epicutaneous immunotherapy treatment for peanut allergy.Tomorrow, as pioneers, we will continue to explore the broad applications of this potential new class of immunotherapy, including treatments for patients suffering from inflammatory and autoimmune diseases.